KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Gains from Sales and Divestitures: 2009-2014

  • Thermo Fisher Scientific's Gains from Sales and Divestitures rose 6.67% to $896,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $896,000, marking a year-over-year increase of 6.67%. This contributed to the annual value of $896,000 for FY2014, which is 6.67% up from last year.
  • According to the latest figures from Q4 2014, Thermo Fisher Scientific's Gains from Sales and Divestitures is $896,000, which was up 6.67% from $840,000 recorded in Q4 2013.
  • Thermo Fisher Scientific's Gains from Sales and Divestitures' 5-year high stood at $896,000 during Q4 2014, with a 5-year trough of $499,000 in Q4 2010.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $840,000 (2013), whereas its average is $752,000.
  • Data for Thermo Fisher Scientific's Gains from Sales and Divestitures shows a peak YoY surged of 61.54% (in 2013) over the last 5 years.
  • Over the past 5 years, Thermo Fisher Scientific's Gains from Sales and Divestitures (Quarterly) stood at $499,000 in 2010, then rose by 1.00% to $504,000 in 2011, then grew by 3.17% to $520,000 in 2012, then soared by 61.54% to $840,000 in 2013, then rose by 6.67% to $896,000 in 2014.
  • Its Gains from Sales and Divestitures stands at $896,000 for Q4 2014, versus $840,000 for Q4 2013 and $520,000 for Q4 2012.